Publication | Open Access

Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling

Hematological MalignancyInhibitor Cx-4945Receptor Tyrosine KinaseMalignant Blood DisorderImmunologyUnfolded Protein ResponseCytotoxic ActivityAdult T-cell Leukemia-lymphomaImmunotherapyMedicineCell BiologyCell SignalingNovel Therapy